Pages that link to "Q51211086"

The following pages link to Hepatocyte and kupffer cells co-cultured on micropatterned surfaces to optimize hepatocyte function (Q51211086):

Displaying 29 items.

• Co-culture systems and technologies: taking synthetic biology to the next level (Q27007227) (← links)
• Advances in Engineered Liver Models for Investigating Drug-Induced Liver Injury (Q28077505) (← links)
• Substrate mediated enzyme prodrug therapy (Q28485159) (← links)
• Stem cell-derived models to improve mechanistic understanding and prediction of human drug-induced liver injury (Q28818235) (← links)
• 3D hepatic cultures simultaneously maintain primary hepatocyte and liver sinusoidal endothelial cell phenotypes (Q33754749) (← links)
• A fast and accessible methodology for micro-patterning cells on standard culture substrates using Parafilm™ inserts (Q33936796) (← links)
• Liver tissue engineering in the evaluation of drug safety (Q33950022) (← links)
• New Methods in Tissue Engineering: Improved Models for Viral Infection (Q35431256) (← links)
• Metabolite profiling and pharmacokinetic evaluation of hydrocortisone in a perfused three-dimensional human liver bioreactor (Q35745230) (← links)
• Microengineered cell and tissue systems for drug screening and toxicology applications: Evolution of in-vitro liver technologies. (Q35826421) (← links)
• Effect of Concentrated Fibroblast-Conditioned Media on In Vitro Maintenance of Rat Primary Hepatocyte (Q35919966) (← links)
• Investigating Nonalcoholic Fatty Liver Disease in a Liver-on-a-Chip Microfluidic Device (Q36082853) (← links)
• Chondrocyte Behavior on Micropatterns Fabricated Using Layer-by-Layer Lift-Off: Morphological Analysis. (Q36663105) (← links)
• Isolation and co-culture of rat parenchymal and non-parenchymal liver cells to evaluate cellular interactions and response (Q36864760) (← links)
• Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. (Q37121662) (← links)
• Designing a multicellular organotypic 3D liver model with a detachable, nanoscale polymeric Space of Disse (Q37222831) (← links)
• Arginine-glycine-aspartic acid-polyethylene glycol-polyamidoamine dendrimer conjugate improves liver-cell aggregation and function in 3-D spheroid culture (Q37234704) (← links)
• Microfluidic platforms for hepatocyte cell culture: new technologies and applications (Q37951402) (← links)
• Organotypic systems in drug metabolism and toxicity: challenges and opportunities (Q38013255) (← links)
• Three-dimensionally engineered biomimetic tissue models for in vitro drug evaluation: delivery, efficacy and toxicity (Q38071670) (← links)
• The application of engineered liver tissues for novel drug discovery (Q38404573) (← links)
• The Promise of New Technologies to Reduce, Refine, or Replace Animal Use while Reducing Risks of Drug Induced Liver Injury in Pharmaceutical Development (Q38774776) (← links)
• Insulin decreases inflammatory signal transcription factor expression in primary human liver cells after LPS challenge (Q40244959) (← links)
• The effectiveness of a novel cartridge-based bioreactor design in supporting liver cells (Q42955998) (← links)
• Numerical simulation of mass transport in a microchannel bioreactor with cell micropatterning (Q47661755) (← links)
• The Protective Effect of Transplanting Liver Cells Into the Mesentery on the Rescue of Acute Liver Failure After Massive Hepatectomy. (Q53173105) (← links)
• Maintaining hepatocyte differentiation in vitro through co-culture with hepatic stellate cells (Q83274871) (← links)
• Advances in generating liver cells from pluripotent stem cells as a tool for modeling liver diseases (Q89506756) (← links)
• Flow-Based Three-Dimensional Co-Culture Model for Long-Term Hepatotoxicity Prediction (Q92354001) (← links)